// App-Quantinova.ai

: Targeted Retreatment of Incompletely Resolved COPD Exacerbations With Ciprofloxacin

Researchers

Presenter

  • Andrew Ritchie

Principal Investigators

  • Simon E. Brill

  • Ben H. Vlies

  • Lydia J Finney

  • James P. Allinson

  • Luana Alves-Moreira

  • Paul Walker

  • Emma Baker

  • Sarah Elkin

  • Patrick Mallia

  • Gavin C. Donaldson

  • Peter M A. Calverley

  • Jadwiga Wedzicha

Medical Centers

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Aintree University Hospital, Liverpool, United Kingdom

  • St George’s University Hospital NHS Foundation Trust, London, UK, London, United Kingdom

  • St Mary’s Imperial Health Care NHS Trust, London, UK, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • C reactive protein

Drug/Treatment

  • Ciprofloxacin

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved